Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus Genotype 1”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01896193
What this trial is testing

Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 127
Testing effectiveness (Phase 2)Study completedNCT03036839
What this trial is testing

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 95
Post-approval studies (Phase 4)Study completedNCT02761629
What this trial is testing

Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 180
Large-scale testing (Phase 3)Study completedNCT02073656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Who this might be right for
Hepatitis C VirusHIV
Gilead Sciences 335
Not applicableStudy completedNCT01514890
What this trial is testing

French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 675
Testing effectiveness (Phase 2)Study completedNCT01371604
What this trial is testing

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 68
Testing effectiveness (Phase 2)Ended earlyNCT01080222
What this trial is testing

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
Vertex Pharmaceuticals Incorporated 152
Testing effectiveness (Phase 2)Study completedNCT00735969
What this trial is testing

High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 21
Not applicableStudy completedNCT04577482
What this trial is testing

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 42
Large-scale testing (Phase 3)Study completedNCT03833362
What this trial is testing

Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

Who this might be right for
Hepatitis C
R-Pharm 420
Large-scale testing (Phase 3)Study completedNCT01241760
What this trial is testing

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Genotype 1 Chronic Hepatitis CTreatment Naive
Janssen Infectious Diseases BVBA 744
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Large-scale testing (Phase 3)Study completedNCT03089944
What this trial is testing

Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 343
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Early research (Phase 1)Study completedNCT01590407
What this trial is testing

First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 71
Testing effectiveness (Phase 2)Study completedNCT00863239
What this trial is testing

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT01628692
What this trial is testing

Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 230
Testing effectiveness (Phase 2)Study completedNCT02350569
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 17
Testing effectiveness (Phase 2)Study completedNCT02219685
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00996476
What this trial is testing

Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 92
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation